MANZI JIM P, Director, subtracted 1,833 shares of Thermo Fisher Scientific Inc. (TMO) from its portfolio at the rate of $272.93 per share valuing $500,279 on Aug 15. The insider left behind 27,892 shares of the company to its portfolio. Before making a move on any particular stock, readers often pay close attention to support and resistance markers. The last reported price for shares of Thermo Fisher Scientific Inc. (TMO) was $269.36. Currently, the 1st Resistance Point for this stock is $277.23, with a 2nd Resistance Point sitting at $285.11. Meanwhile, this company’s stock has a 1st Support Level at $264.47 and a 2nd Support Level at $259.59. Thermo Fisher Scientific Inc. (TMO) stock has lost -$6.79, or -2.46%, in the past five days. In the last full month, these shares have lost -$24.26, or -8.26%. In the past three months, this stock’s price has fallen by -$1.66, or -0.61%. This year-to-date, Thermo Fisher Scientific Inc. (TMO) shares have gained $45.57, or 20.36%.
Analyzing price projection indicators is a helpful way to determine whether a potential stock buy is a wise choice for profits in the short term, medium term, and long term. For Thermo Fisher Scientific Inc. (TMO) stock, 50% of short-term indicators suggest that these shares are a “ Sell .” Meanwhile, 50% of medium-term indicators point to this stock being a “ Buy .”
With 400,476 K shares outstanding, this company currently has a market capitalization of $107,872,216K. Thermo Fisher Scientific Inc. (TMO) generates $24,358 M in annual sales, amounting to annual net income of $2,938 M. This stock has generated a 1-Year Total Return of 15.02%, a 3-Year Total Return of 76.79%, and a 5-year Total Return of 124.07%. This stock’s 5-Year Dividend Growth is 13.33%, with its most recent dividend valued at $0.190 per share on 06/13/19. Its Annual Dividend Yield is 0.28%, and its Annual Dividend Rate is 0.76.
In the most recently-reported fiscal quarter, which ended in Jun-19, Thermo Fisher Scientific Inc. (TMO) reported earnings of $3.04 per share. Wall Street analysts, on average, were expecting the company to report earnings of $3.00 per share, representing a 0.04 difference and 1.44% surprise. In the previous quarter ending in Mar-19, the reported earnings of $2.81 represented a 0.08 difference from the consensus estimate calling for $2.73 per share, which was a 2.91% surprise.
For the current fiscal quarter, which is set to end in 09/2019, the average earnings estimate is $2.88 per share. This estimate came from a total of 8 Wall Street Analysts. Of those market experts, the high estimate was $3.00 and the low estimate was $2.83. In the year-ago quarter, Thermo Fisher Scientific Inc. (TMO) generated per-share earnings of $2.62. If the analysts are correct about the current quarter’s earnings, the growth will be +9.92%.
Turning our focus now to insider trading activity, there have been 1 purchases (50,000 shares in total) and 11 sale (63,604 shares in total) in the last 3 months. In the last 6 months, there have been 14 insider buys amounting to 108,611 shares and 37 insider sales amounting to 145,306 shares. In the past full year, 39 insider purchases were made (involving 405,244 shares) and 75 insider sell-offs equivalent to 353,154 shares.
Moving onto liquidity, Thermo Fisher Scientific Inc. (TMO) has a Current Ratio of 1.73, a Quick Ratio of 1.24 and a Cash Ratio of 0.34. Looking at this company’s capital structure, its Total Debt to Total Equity is 68.84, its Total Debt to Total Capital is 40.77, and its Total Debt to Total Assets is now 33.77. Looking even further ahead into the future, its Long-Term Debt to Equity is 64.23 and its Long-Term Debt to Total Capital is 38.04.